Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Feb:103:402-403.
doi: 10.1016/j.ijid.2020.12.010. Epub 2020 Dec 9.

More gastro-intestinal adverse events in non-ICU hospitalised COVID-19 patients treated with chloroquine versus hydroxychloroquine

S Verheijen  1 , M van Luin  2 , R J Brüggemann  3 , Q de Mast  3 , R J Hassing  2 , D M Burger  3
Affiliations
Comment

More gastro-intestinal adverse events in non-ICU hospitalised COVID-19 patients treated with chloroquine versus hydroxychloroquine

S Verheijen et al. Int J Infect Dis. 2021 Feb.
No abstract available

PubMed Disclaimer

Comment on

  • Early hydroxychloroquine but not chloroquine use reduces ICU admission in COVID-19 patients.
    Lammers AJJ, Brohet RM, Theunissen REP, Koster C, Rood R, Verhagen DWM, Brinkman K, Hassing RJ, Dofferhoff A, El Moussaoui R, Hermanides G, Ellerbroek J, Bokhizzou N, Visser H, van den Berge M, Bax H, Postma DF, Groeneveld PHP. Lammers AJJ, et al. Int J Infect Dis. 2020 Dec;101:283-289. doi: 10.1016/j.ijid.2020.09.1460. Epub 2020 Sep 29. Int J Infect Dis. 2020. PMID: 33007454 Free PMC article.

References

    1. Liu J., Cao R., Xu M., Wang X., Zhang H., Hu H., et al. Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro. Cell Discov. 2020;6 doi: 10.1038/s41421-020-0156-0. - DOI - PMC - PubMed
    1. Pereira B.B. Challenges and cares to promote rational use of chloroquine and hydroxychloroquine in the management of coronavirus disease 2019 (COVID-19) pandemic: a timely review. J Toxicol Environ Health B Crit Rev. 2020;23(4):177–181. doi: 10.1080/10937404.2020.1752340. - DOI - PMC - PubMed
    1. Yao X., Ye F., Zhang M., Cui C., Huang B., Niu P., et al. In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Clin Infect Dis. 2020;71(15):732–739. doi: 10.1093/cid/ciaa237. - DOI - PMC - PubMed

LinkOut - more resources